Head-to-Head Test of Two Sarcoma Survival Calculators Favors the Older Model
A small Turkish retrospective study found the MSKCC nomogram discriminated survival better than Sarculator in extremity soft tissue sarcoma, though ...
A small Turkish retrospective study found the MSKCC nomogram discriminated survival better than Sarculator in extremity soft tissue sarcoma, though ...
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Researchers built an explainable random survival forest model that predicts overall and cancer-specific survival in postoperative gastrointestinal stromal tumor patients, ...
A propensity score-matched study of 153 patients suggests adjuvant radiotherapy does not improve overall or recurrence-free survival in limb liposarcoma, ...
A ten-year single-center study reports 94 percent primary efficacy and 100 percent cancer-specific survival at five years for image-guided ablation ...
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
A multicenter study of 167 lung cancer patients found that persistent emotional distress across neoadjuvant therapy and surgery was independently ...
A multicenter Austrian study finds that whether primary CNS lymphoma shrinks or grows on MRI after routine corticosteroid therapy strongly ...
A real-world Chinese cohort study finds that a PET-based International Metabolic Prognostic Index refines risk prediction for diffuse large B-cell ...
A systematic review of 32 studies finds that proton craniospinal irradiation is associated with reported median survival of 10.7 months ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine